Skip to content
healthcare.dev

Mucinex DM

NDC 67751-171, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, tablet, extended release, from Navajo Manufacturing Company Inc..

Product NDC
67751-171
Status
Listed
Labeler
Navajo Manufacturing Company Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
NDA
Application
NDA021620
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67751-171 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEXTROMETHORPHAN HYDROBROMIDE30 mg/1
  • GUAIFENESIN600 mg/1

Pharmacologic classes

Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; Sigma-1 Agonist [EPC]; Sigma-1 Receptor Agonists [MoA]; Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]; Uncompetitive NMDA Receptor Antagonists [MoA]

Package NDCNDC-11Package
67751-171-01677510171011 POUCH in 1 CARTON (67751-171-01) / 2 TABLET, EXTENDED RELEASE in 1 POUCH

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 67751-171 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67751-171 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67751-171. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.